Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Poynard

Showing results (101-110 of 272) with videos related to

Pageof 28
Sort By:
BMJ Open|December 25, 2015
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activityThierry Poynard, Olivier Deckmyn, Mona Munteanu, et al.
Gastroenterologie Clinique Et Biologique|February 21, 2003
[Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis]Lamia Golli, Julien Taïeb, Emmanuel Boleslawski, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative studyPierre Pradat, Alfredo Alberti, Thierry Poynard, et al.
Journal of Leukocyte Biology|December 19, 2002
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophilsJulien Taïeb, Charlotte Delarche, Fréderic Ethuin, et al.
Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Can metabolic steatohepatitis be treated?]Vlad Ratziu, Maria Vispo, Mohamed Tahiri, et al.
European Journal of Gastroenterology & Hepatology|December 28, 2017
Impact of steatosis and inflammation definitions on the performance of NASH testsThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.
Gastroenterology & Hepatology|February 3, 2012
Prognostic value of liver fibrosis biomarkers: a meta-analysisThierry Poynard, Yen Ngo, Hugo Perazzo, et al.
Antiviral Therapy|July 1, 2010
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studiesThierry Poynard, Yen Ngo, Mona Munteanu, et al.
Gastroenterology|June 9, 2005
Sampling variability of liver biopsy in nonalcoholic fatty liver diseaseVlad Ratziu, Frédéric Charlotte, Agnès Heurtier, et al.
Pageof 28

Showing results (101-110 of 272) with videos related to

Sort By:
Pageof 28
BMJ Open|December 25, 2015
Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activityThierry Poynard, Olivier Deckmyn, Mona Munteanu, et al.
Gastroenterologie Clinique Et Biologique|February 21, 2003
[Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis]Lamia Golli, Julien Taïeb, Emmanuel Boleslawski, et al.
Hepatology (Baltimore, Md.)|September 26, 2002
Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative studyPierre Pradat, Alfredo Alberti, Thierry Poynard, et al.
Journal of Leukocyte Biology|December 19, 2002
Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophilsJulien Taïeb, Charlotte Delarche, Fréderic Ethuin, et al.
Gastroenterology|May 2, 2002
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis CThierry Poynard, John McHutchison, Michael Manns, et al.
Gastroenterologie Clinique Et Biologique|March 31, 2007
[Can metabolic steatohepatitis be treated?]Vlad Ratziu, Maria Vispo, Mohamed Tahiri, et al.
European Journal of Gastroenterology & Hepatology|December 28, 2017
Impact of steatosis and inflammation definitions on the performance of NASH testsThierry Poynard, Mona Munteanu, Frederic Charlotte, et al.
Gastroenterology & Hepatology|February 3, 2012
Prognostic value of liver fibrosis biomarkers: a meta-analysisThierry Poynard, Yen Ngo, Hugo Perazzo, et al.
Antiviral Therapy|July 1, 2010
Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studiesThierry Poynard, Yen Ngo, Mona Munteanu, et al.
Gastroenterology|June 9, 2005
Sampling variability of liver biopsy in nonalcoholic fatty liver diseaseVlad Ratziu, Frédéric Charlotte, Agnès Heurtier, et al.
Pageof 28